{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:15:35Z","timestamp":1788552935458,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.colsurfb.2026.116047","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:21:19Z","timestamp":1785770479000},"page":"116047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Engineered tumor cell membrane-coated manganese-amplified STING nanoagonist potentiates PD-L1 blockade immunotherapy in non-small cell lung cancer"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9734-0260","authenticated-orcid":false,"given":"Ye","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.116047_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41571-025-01080-4","article-title":"Unresectable stage III non-small-cell lung cancer: state of the art and challenges","volume":"23","author":"Remon","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib2","first-page":"387","article-title":"Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management","volume":"75","author":"Borgeaud","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.colsurfb.2026.116047_bib3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S1470-2045(25)00429-2","article-title":"Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis","volume":"26","author":"Di Federico","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41590-024-01859-0","article-title":"Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade","volume":"25","author":"Fortin","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","article-title":"Single-cell meta-analyses reveal responses of tumor-reactive CXCL13(+) T cells to immune-checkpoint blockade","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116047_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.colsurfb.2026.116047_bib7","article-title":"Piezo1 Activation Improves NSCLC Liver Metastasis Immunotherapy by Overriding Matrix Stiffness-Mediated Bimodal PD-L1\/CXCL10 Regulation","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.colsurfb.2026.116047_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2026.116047_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116047_bib10","article-title":"The cGAS\/STING Pathway: A Novel Target for Cancer Therapy","volume":"12","author":"Gan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","article-title":"cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation","volume":"22","author":"Liu","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.colsurfb.2026.116047_bib12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cac2.70067","article-title":"Breaking barriers: The cGAS-STING pathway as a novel frontier in cancer immunotherapy","volume":"45","author":"Yan","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.colsurfb.2026.116047_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl4089","article-title":"MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists","volume":"390","author":"Hsu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.colsurfb.2026.116047_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2026.116047_bib15","article-title":"STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy","volume":"12","author":"Gehrcken","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.colsurfb.2026.116047_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111914","article-title":"STING agonists: a range of eminent mediators in cancer immunotherapy","volume":"134","author":"Wen","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.colsurfb.2026.116047_bib17","article-title":"Manganese-based tumor immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2026.116047_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","article-title":"Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses","volume":"48","author":"Wang","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.colsurfb.2026.116047_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-025-02242-9","article-title":"Multimodal lung cancer theranostics via manganese phosphate\/quercetin particle","volume":"24","author":"Qiu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116047_bib20","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1002\/anie.202004894","article-title":"MOF-derived double-layer hollow nanoparticles with oxygen generation ability for multimodal imaging-guided sonodynamic therapy","volume":"59","author":"Pan","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.colsurfb.2026.116047_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.colsurfb.2026.116047_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-024-02099-4","article-title":"LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116047_bib23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S1470-2045(25)00462-0","article-title":"Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study","volume":"26","author":"Hata","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib24","article-title":"Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer","volume":"5","author":"Chakraborty","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.colsurfb.2026.116047_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2025.09.023","article-title":"Hybrid cell-membrane-coated biomimetic nanoparticles for targeted noninvasive intervention in early diabetic retinopathy","author":"Yang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2026.116047_bib26","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.7150\/thno.128136","article-title":"Biomimetic Cell Membrane-coated Nanovaccines in Anti-tumor Immunotherapy","volume":"16","author":"Chen","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2026.116047_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114759","article-title":"Macrophage-membrane-engineered NIR II biomimetic nanomaterials for enhanced synergistic chemo-photothermal immunotherapy in cancer treatment","volume":"253","author":"Yao","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2026.116047_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.115003","article-title":"Biomimetic anlotinib-loaded FePc-silicate nanoparticles for sonodynamic and immunotherapy in non-small cell lung cancer via dual PD-L1 modulation","volume":"256","author":"Liu","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2026.116047_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1186\/s12885-025-14433-0","article-title":"Biomimetic cancer cell membrane engineered lipid nanoparticles for enhanced chemotherapy of homologous malignant tumor","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.colsurfb.2026.116047_bib30","article-title":"Biomimetic membrane-coated nanoparticles for targeted synergistic therapy of homocysteine-induced atherosclerosis: dual modulation of cholesterol efflux and reactive oxygen species scavenging","volume":"33","author":"Ding","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.colsurfb.2026.116047_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.actbio.2021.03.051","article-title":"Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma","volume":"127","author":"Cai","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2026.116047_bib32","article-title":"A tumor microenvironment-responsive Zr-MOF nanosystem for co-delivering siHIF-1\u03b1 and triptolide enhances photodynamic therapy in esophageal cancer by amplifying ROS generation and reversing hypoxia","volume":"34","author":"Liu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.colsurfb.2026.116047_bib33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41563-021-01042-y","article-title":"Microenvironment-triggered multimodal precision diagnostics","volume":"20","author":"Hao","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.colsurfb.2026.116047_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib35","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","article-title":"Systematic design of cell membrane coating to improve tumor targeting of nanoparticles","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2026.116047_bib36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib37","doi-asserted-by":"crossref","first-page":"15977","DOI":"10.1021\/acsnano.2c03509","article-title":"Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy","volume":"16","author":"Song","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116047_bib38","first-page":"53","article-title":"Manganese molybdate nanodots with dual amplification of STING activation for \"cycle\" treatment of metalloimmunotherapy","volume":"31","author":"Lei","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2026.116047_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12951-025-03608-3","article-title":"Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation","volume":"23","author":"Xu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116047_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116047_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110814","article-title":"WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC","volume":"39","author":"Taniguchi","year":"2022","journal-title":"Cell. Rep."},{"key":"10.1016\/j.colsurfb.2026.116047_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092160","article-title":"STING-activating nanoparticles combined with PD-1\/PD-L1 blockade: a synergistic approach in cancer immunotherapy","volume":"13","author":"Bartusik-Aebisher","year":"2025","journal-title":"Biomedicines"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526006351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526006351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:49:55Z","timestamp":1788551395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526006351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0927776526006351"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116047","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered tumor cell membrane-coated manganese-amplified STING nanoagonist potentiates PD-L1 blockade immunotherapy in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116047"}}